Conference item icon

Conference item

Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)

Publication status:
Published
Peer review status:
Reviewed (other)
Version:
Accepted Manuscript

Actions


Access Document


Files:

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Subgroup:
NDM Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Subgroup:
NDM Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Subgroup:
NDM Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Subgroup:
NDM Experimental Medicine
Role:
Author
Expand authors...
Publisher:
American Thoracic Society Publisher's website
Volume:
199
Pages:
A3826
Publication date:
2019-05-22
Acceptance date:
2019-01-01
EISSN:
1535-4970
ISSN:
1073-449X
Pubs id:
pubs:1003696
URN:
uri:c2a94f0e-257e-4c1e-b780-25ce83bb347c
UUID:
uuid:c2a94f0e-257e-4c1e-b780-25ce83bb347c
Local pid:
pubs:1003696

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP